Home›Companies›Healthcare›PECA Labs

Peca Labs, Inc.

Develops cardiovascular implants for patients needing vascular grafts or heart valve reconstruction.

Updated Nov 9, 2026·Latest SEC filing Oct 9, 2026·Suggest an edit

About PECA Labs

PECA Labs is a private company based in Pittsburgh, Pennsylvania. It has reported $34,207,421 raised in ten offerings on Form D since May 2015. Its chief executive is C. Douglas Bernstein.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 30, 2026Oct 9, 2026$12,789,342of $21.4M target30$426KEquityRule 506(b)Form D ↗
Nov 6, 2025Nov 20, 2025$2,650,037of $5.0M target18$147KEquityRule 506(b)Form D ↗
Dec 12, 2024Dec 27, 2024$13,925,680of $16.5M target32$435KEquity, Securities on exerciseRule 506(b)Form D ↗
Nov 9, 2022Nov 18, 2022$618,177target not set6$103KDebtRule 506(b)Form D ↗
Jun 30, 2021Jul 7, 2021$99,240of $1.8M target1$99,240EquityRule 506(b)Form D ↗
Jun 5, 2020Jun 15, 2020$587,465of $2.0M target5$117KEquityRule 506(b)Form D ↗
Jan 18, 2019Feb 4, 2019$93,817of $1.6M target1$93,817EquityRule 506(b)Form D ↗
Jan 23, 2018Feb 5, 2018$1,400,006fully sold4$350KEquityRule 506(b)Form D ↗
Nov 7, 2016Nov 18, 2016$749,986fully sold5$149KEquityRule 506(b)Form D ↗
Apr 22, 2015May 6, 2015$1,293,671of $2.7M target9$143KEquityRule 506(b)Form D ↗
Total, ten offerings$34,207,421

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PECA Labs's Form D filed Oct 9, 2026.

C. Douglas Bernstein
C. Douglas Bernstein
Chief Executive Officer and director
BD
Bob Donohue
Director
JK
Jon Kuhn
Director
BC
Samuel Navarro
Samuel Navarro
COO and director
Also a director at Accure Acne.
JB
JD

Earlier filings also listed Michael Moriarty (director, last listed Nov 2025), Dr. Joseph Bavaria (director, last listed Nov 2025), Dr. Jeffrey Carpenter (director, last listed Nov 2025), Brandon Haynes (director, last listed Nov 2025), James Browne (director, last listed Nov 2022), Douglas Bernstein (executive officer and director, last listed Nov 2022), David Smith (secretary, last listed Nov 2022) and Robert Dickson (director, last listed Jul 2021).

Sources

  1. SECPeca Labs, Inc. filing history
  2. ResearchFDA correspondence